Session Abstract – PMWC 2022 Silicon Valley

 Session Chair Profile

M.D., M.P.H., CEO, CancerLinQ

Biography
Dr. Khozin is an oncologist and physician-scientist, currently serving as Chief Executive Officer of CancerLinQ, a company focused on advancing cancer care quality and research. Previously, he was Global Head of Data Strategy and Data Science Innovation at J&J, leading a worldwide multidisciplinary team charged with the design and implementation of pioneering data science solutions to support the development of innovative medicines. Before joining J&J, Dr. Khozin led FDA Oncology Center of Excellence’s bioinformatics, regulatory science, and clinical trial innovation efforts and was the founding Executive Director of Information Exchange and Data Transformation (INFORMED), the FDA’s first data science and technology incubator that played a pivotal role in the agency’s technology modernization efforts. Before his tenure in federal government, Dr. Khozin was the cofounder of Hello Health, a company focused on developing integrated telemedicine, point-of-care data visualization, and advanced analytical systems for optimizing patient care and clinical research.

Talk
AI Roadmap: Opportunities and Challenges
This session outlines current challenges and opportunities related to the use of AI to advance therapeutic development and care delivery, with a special focus on medical imaging.


 Speaker Profile

Ph.D., SVP Clinical Data Sciences, Gilead

Biography
Patrick Loerch has over 20 years of experience in data sciences, real world evidence and genomics research spanning all phases of R&D within the pharmaceutical industry. Dr Loerch currently serves as Senior Vice President, Clinical Data Sciences at Gilead Sciences. In addition to oversight of the Biometrics, Clinical Bioinformatics and Real World Evidence organizations, Dr. Loerch is accountable for the build out and integration of Enterprise Data Sciences capabilities to accelerate the discovery, development and delivery of new medicines. Dr. Loerch’s prior roles include leadership positions at Johnson & Johnson, Celgene and Merck. He began his career at Rosetta Inpharmatics, a genomics start-up in Seattle, WA that was later acquired by Merck. Dr. Loerch received his PhD in Biostatistics from the Harvard University and his BS in Biochemistry from Washington State University.


 Speaker Profile

CEO, Xerion Precision Bio

Biography
Investor & patients' advocate in systems biology, precision neuroscience. Served on steering committee of the MIT/UCSB Alzheimer’s X initiative, and is on the financing structure committee of the American Medical Association/One Mind Healthy Brain Global Initiative; and the corporate advisory Board of Cancer Expert Now. Adviser to CEO of CancerLinq. Dan is a multi-asset class investor, lawyer and social entrepreneur whose 35-year career has been defined by purposeful engagement as an adviser and investor in important global developments, most recently through his $3.5 Billion Xerion Hedge Funds.

Talk
Data Analytics Is Only As Good As The Data
Quality analysis depends on quality inputs. Fully realizing AI's potential for precision medicine will require multi-dimensional mosaic of data input, including biomarker analytes, biomedical interventions, treatment effects and secondary treatments.


 Speaker Profile

M.D., Ph.D., Professor of Medicine, Stanford University; Chief Data Scientist, Stanford Health Care

Biography
Dr. Nigam Shah is Professor of Medicine (Biomedical Informatics) at Stanford University, and serves as the Associate CIO for Data Science for Stanford Health Care. Dr. Shah's research focuses on bringing machine learning to clinical use safely, ethically and cost-effectively. Dr. Shah was elected into the American College of Medical Informatics (ACMI) in 2015 and was inducted into the American Society for Clinical Investigation (ASCI) in 2016. He holds an MBBS from Baroda Medical College, India, a PhD from Penn State University and completed postdoctoral training at Stanford University.


 Speaker Profile

Ph.D., Co-Founder & CEO, Recursion

Biography
Chris developed the technology and approach that seeded Recursion as part of his MD/PhD work in the lab of Co-Founder Dr. Dean Li (current President of Merck Research Labs) while at the University of Utah. After completing his Ph.D., Chris left medical school to build Recursion into the rapidly growing company it is today. Chris is a graduate of Rice University with degrees in bioengineering and management. Chris serves on the Board of BioUtah and is the Chair of BioHive, the public-private partnership driving expansion of Utah's life-science ecosystem, the fastest growing in the nation. Chris is also active as an advisor and mentor, both formally and informally, of many young biotech founders. Chris enjoys cycling on both the road and the trails that cut through Utah's great wilderness, as well as spending time with family.


 Speaker Profile

M.D., Principal AI/ML, Amazon

Biography
Dr Lungren was an interventional radiologist and research faculty at Stanford University Medical School where he led the Stanford Center for Artificial Intelligence in Medicine and Imaging (AIMI). He served as advisor for dozens of early stage startups and large fortune-500 companies on healthcare AI go-to-market strategy. His work has led to more than 100 scientific publications. Dr. Lungren is frequently featured in national news outlets such as NPR, Vice News, Scientific American, and he regularly speaks at national and international scientific meetings on the topic of AI in healthcare. Finally, Dr. Lungren is also a top rated instructor on Coursera where his AI in Healthcare course designed especially for learners with non-technical backgrounds has been completed by more than 10k students around the world.